3EDH.A | BMP1

General Structure Information 3edh BMP1 crystal structure of bone morphogenetic protein 1 protease domain in complex with partially bound dmso 1.25Å AUTH A.MAC SWEENEY,S.G.PARRADO,D.VINZENZ,A.BERNARDI,AUTH 2 A.HEIN,U.BODENDORF,P.ERBEL,C.LOGEL,B.GERHARTZTITL STRUCTURAL BASIS FOR THE SUBSTRATE SPECIFICITY OFTITL 2 BONE MORPHOGENETIC PROTEIN 1/TOLLOID-LIKETITL 3 METALLOPROTEASESREF TO BE PUBLISHEDREFN Variant Set Distributions Mapped Variants

See Details
1ZCM.A | CAPN1

General Structure Information 1zcm CAPN1 human calpain protease core inhibited by zllych2f 2.0Å AUTH Q.LI,R.P.HANZLIK,R.F.WEAVER,E.SCHONBRUNNTITL MOLECULAR MODE OF ACTION OF A COVALENTLYTITL 2 INHIBITING PEPTIDOMIMETIC ON THE HUMAN CALPAINTITL 3 PROTEASE COREREF BIOCHEMISTRY V. 45 701 2006REFN ISSN 0006-2960PMID 16411745DOI 10.1021/BI052077B Variant Set Distributions Mapped Variants

See Details
1GMY.A | CTSB

General Structure Information 1gmy CTSB cathepsin b complexed with dipeptidyl nitrile inhibitor 1.9Å AUTH P.D.GREENSPAN,K.L.CLARK,R.A.TOMMASI,S.D.COWEN,AUTH 2 L.W.MCQUIRE,D.L.FARLEY,J.H.VAN DUZER,R.L.GOLDBERG,AUTH 3 H.ZHOU,Z.DU,J.J.FITT,D.E.COPPA,Z.FANG,W.MACCHIA,AUTH 4 L.ZHU,M.P.CAPPARELLI,R.GOLDSTEIN,A.M.WIGG,AUTH 5 J.R.DOUGHTY,R.S BOHACEK,A.K.KNAPTITL IDENTIFICATION OF DIPEPTIDYL NITRILES AS POTENTTITL 2 AND SELECTIVE INHIBITORS OF CATHEPSIN B THROUGHTITL 3 STRUCTURE-BASED DRUG DESIGNREF J.MED.CHEM. V. 44 4524 2001REFN ISSN 0022-2623PMID 11741472DOI 10.1021/JM010206Q Variant Set Distributions […]

See Details
3FUK.A | LTA4H

General Structure Information 3fuk LTA4H leukotriene a4 hydrolase in complex with 1-[2-(1h-indol-5- yloxy)ethyl]piperidine-4-carboxylic acid 1.95Å AUTH D.R.DAVIES,B.MAMAT,O.T.MAGNUSSON,J.CHRISTENSEN,AUTH 2 M.H.HARALDSSON,R.MISHRA,B.PEASE,E.HANSEN,J.SINGH,AUTH 3 D.ZEMBOWER,H.KIM,A.S.KISELYOV,A.B.BURGIN,AUTH 4 M.E.GURNEY,L.J.STEWARTTITL DISCOVERY OF LEUKOTRIENE A4 HYDROLASE INHIBITORSTITL 2 USING METABOLOMICS BIASED FRAGMENT CRYSTALLOGRAPHY.REF J.MED.CHEM. V. 52 4694 2009REFN ISSN 0022-2623PMID 19618939DOI 10.1021/JM900259H Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic […]

See Details
1JMO.A | SERPIND1

General Structure Information 1jmo SERPIND1 crystal structure of the heparin cofactor ii-s195a thrombin complex 2.2Å AUTH T.P.BAGLIN,R.W.CARRELL,F.C.CHURCH,C.T.ESMON,J.A.HUNTINGTONTITL CRYSTAL STRUCTURES OF NATIVE AND THROMBIN-COMPLEXED HEPARINTITL 2 COFACTOR II REVEAL A MULTISTEP ALLOSTERIC MECHANISM.REF PROC.NATL.ACAD.SCI.USA V. 99 11079 2002REFN ISSN 0027-8424PMID 12169660DOI 10.1073/PNAS.162232399 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped […]

See Details
2F83.A | F11

General Structure Information 2f83 F11 crystal structure at 2.9 angstroms resolution of human plasma coagulation factor xi zymogen 2.87Å AUTH E.PAPAGRIGORIOU,P.A.MCEWAN,P.N.WALSH,J.EMSLEYTITL CRYSTAL STRUCTURE OF THE FACTOR XI ZYMOGEN REVEALS A PATHWAYTITL 2 FOR TRANSACTIVATION.REF NAT.STRUCT.MOL.BIOL. V. 13 557 2006REFN ISSN 1545-9993PMID 16699514DOI 10.1038/NSMB1095 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants

See Details
1LQ8.G | SERPINA5

General Structure Information 1lq8 SERPINA5 crystal structure of cleaved protein c inhibitor 2.4Å AUTH J.A.HUNTINGTON,M.KJELLBERG,J.STENFLOTITL CRYSTAL STRUCTURE OF PROTEIN C INHIBITOR PROVIDES INSIGHTSTITL 2 INTO HORMONE BINDING AND HEPARIN ACTIVATIONREF STRUCTURE V. 11 205 2003REFN ISSN 0969-2126PMID 12575940DOI 10.1016/S0969-2126(02)00944-9 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
1LQ8.B | SERPINA5

General Structure Information 1lq8 SERPINA5 crystal structure of cleaved protein c inhibitor 2.4Å AUTH J.A.HUNTINGTON,M.KJELLBERG,J.STENFLOTITL CRYSTAL STRUCTURE OF PROTEIN C INHIBITOR PROVIDES INSIGHTSTITL 2 INTO HORMONE BINDING AND HEPARIN ACTIVATIONREF STRUCTURE V. 11 205 2003REFN ISSN 0969-2126PMID 12575940DOI 10.1016/S0969-2126(02)00944-9 Variant Set Distributions Mapped Variants

See Details
2VWM.A | F10

General Structure Information 2vwm F10 aminopyrrolidine factor xa inhibitor 1.96Å AUTH K.G.ZBINDEN,L.ANSELM,D.W.BANNER,J.M.BENZ,F.BLASCO,AUTH 2 G.DECORET,J.HIMBER,B.KUHN,N.PANDAY,F.RICKLIN,AUTH 3 P.RISCH,D.SCHLATTER,M.STAHL,S.THOMI,R.UNGER,W.HAAPTITL DESIGN OF NOVEL AMINOPYRROLIDINE FACTOR XATITL 2 INHIBITORS FROM A SCREENING HIT.REF EUR.J.MED.CHEM. V. 44 2787 2009REFN ISSN 0223-5234PMID 19200624DOI 10.1016/J.EJMECH.2008.12.025 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details
3BT1.A | PLAU

General Structure Information 3bt1 PLAU structure of urokinase receptor, urokinase and vitronectin complex 2.8Å AUTH Q.HUAI,A.ZHOU,L.LIN,A.P.MAZAR,G.C.PARRY,J.CALLAHAN,D.E.SHAW,AUTH 2 B.FURIE,B.C.FURIE,M.HUANGTITL CRYSTAL STRUCTURES OF TWO HUMAN VITRONECTIN, UROKINASE ANDTITL 2 UROKINASE RECEPTOR COMPLEXESREF NAT.STRUCT.MOL.BIOL. V. 15 422 2008REFN ISSN 1545-9993PMID 18376415DOI 10.1038/NSMB.1404 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped Variants

See Details